Antidepressants, suicide, and the FDA: a loose association

Ann Pharmacother. 2004 Oct;38(10):1739-42. doi: 10.1345/aph.1E247. Epub 2004 Aug 31.
No abstract available

MeSH terms

  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Drug Labeling
  • Humans
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Suicide*
  • United States
  • United States Food and Drug Administration*

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors